Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

19
Number of overlapping holdings
63.3%
% of FBT's 31 holdings also in XBI
14.3%
% of XBI's 134 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FBT |
Weight in XBI |
Overlap | |
---|---|---|---|---|
NEUROCRINE BIOSCIENCES INC | 3.4% | 2.8% | 2.8% | |
ALNYLAM PHARMACEUTICALS INC | 3.6% | 2.5% | 2.5% | |
NATERA INC | 3.2% | 2.5% | 2.5% | |
GILEAD SCIENCES INC | 3.4% | 2.5% | 2.5% | |
AMGEN INC | 3.4% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to XBI
CORCEPT THERAPEUTICS INC | 4.2% | |
INTRA-CELLULAR THERAPIES INC | 4.2% | |
BEIGENE LTD. SPONSORED ADR | 4.0% | |
METTLER-TOLEDO INTERNATIONAL | 3.6% | |
WATERS CORP | 3.5% | |
REPLIGEN CORP | 3.4% | |
BIONTECH SE SPONSORED ADR | 3.2% | |
ARGENX SE ADR | 3.2% | |
ILLUMINA INC | 3.1% | |
BRUKER CORP | 3.0% |
FBT Underweight Relative to XBI
ABBVIE INC | -2.5% | |
INSMED INC | -2.4% | |
VAXCYTE, INC. | -2.3% | |
MADRIGAL PHARMACEUTICALS, INC. | -1.9% | |
TG THERAPEUTICS INC | -1.8% | |
BLUEPRINT MEDICINES CORP. | -1.7% | |
VIKING THERAPEUTICS, INC. | -1.5% | |
BRIDGEBIO PHARMA, INC. | -1.5% | |
ADMA BIOLOGICS, INC. | -1.4% | |
CYTOKINETICS INC | -1.4% |